In 1990, the US Food and Drug Administration (FDA) requested Astra to change Losec’s brand name to Prilosec, to avoid confusion with Sanofi-Aventis’ diuretic, Lasix (furosemide).

The Food and Drug Administration says it will begin offering faster reviews to new medicines that align with Trump administration priorities for Americans' health. The new program announced ...

Why FDA approval of new HIV prevention drug is a big deal The U.S. Food and Drug Administration has approved the drug lenacapavir as a twice-yearly injection to prevent HIV.

How GLP-1s might be wrecking your fertility GLP-1 drugs help people slim down by curbing their appetite — but that can lead to serious nutrient deficiencies if you aren’t careful. “Clinical ...

Tesla CEO Elon Musk released the results of a drug test on X to counter the New York Times’ reporting that his drug use was “more intense" in the 2024 election.

How should you decide what medications to take when evacuating? Generic Equivalents. (Photo By BSIP/UIG Via Getty Images) Have a list of all your medications and their dosage readily available in ...

A popular Mexican band has been fined more than $36,000 for performing songs glorifying drug cartels, authorities in the northern city of Chihuahua announced Wednesday. At a Los Tucanes de Tijuana ...

The country’s medicines regulator has approved the use of a GLP-1 weight-loss drug to treat people with sleep apnoea for the first time, broadening the applications for the popular drugs beyond ...

U.S. drug companies are increasingly licensing experimental medicines invented by Chinese firms. Recent deals could be worth up to $25 billion.

Despite an increase in the prevalence of prescribing, only 0.5% of U.S. adolescents with obesity were prescribed an obesity medication in 2023, according to research published in the June 5 issue ...

India's pharma sector is at a turning point as the government seeks to strengthen local manufacturing through an upgraded drugs PLI scheme. With a growing market projected to reach $22 billion by ...

FDA's long-standing accelerated approval program generally issues decisions in six months for drugs that treat life-threatening diseases. Regular drug reviews take about 10 months.